Updated 24m ago

generalnews.media

AI reads 36 sources every 2 hours and ranks each story by importance from 1 to 5 - so you see what actually matters.

Showing 500 most recent of 2136 stories
Exclusive

Post examines the future of the firm

OpenAI published a blog post titled The future of the firm. It appears to discuss how companies and organizations may evolve, but the headline alone does not indicate a specific product or policy announcement. It is informative for tracking OpenAI’s views on AI’s role in business.

science

Legora builds an agentic operating system for legal work

Legal tech company Legora is developing an agentic operating system designed to run AI-driven workflows for legal work, featured on OpenAI's blog. The platform aims to let law firms and legal teams delegate document-heavy tasks to AI agents. It reflects the broader push to apply agentic AI to specialized professional services.

Exclusive

Analysis: The Most Important Part of AI Chatbots Is Being Overlooked

New Scientist published an analysis arguing that a crucial component of AI chatbots is being widely ignored. The piece examines why this neglected element matters for how chatbots are designed, evaluated and used. It adds to the broader debate over how AI systems should be built and held accountable.

Exclusive

C. perfringens delta toxin targets CD9 to drive NEC and brain injury

Researchers report that Clostridium perfringens delta toxin binds CD9 and that this interaction drives necrotizing enterocolitis (NEC) and associated brain injury. The study identifies a mechanistic link between a bacterial toxin and severe neonatal intestinal and neurological damage. It may help guide strategies to prevent or treat NEC-related injury in vulnerable infants.

Exclusive

Alzheimer’s genetics points to microglial and neuronal dysfunction

A Nature study finds that Alzheimer’s disease genetic risk converges on dysregulation in microglia, the brain’s immune cells, and neurons. The convergence highlights immune and neuronal mechanisms that may help guide targeted treatments and biomarkers.

Exclusive

Personalization and psychedelics are revitalizing psychiatry

Nature reports that personalized treatment approaches and psychedelic-assisted therapies are helping renew interest and innovation in psychiatry. Researchers and clinicians see potential for new options in mental health care, while questions remain about evidence, safety, and regulation.

Exclusive

Preprint-centric publishing model gains major backing

Nature reports that a preprint-centric approach to scholarly publishing has received a significant boost. The development could affect how researchers share and review findings before formal journal publication. It matters because it may speed up research dissemination and shift incentives in academic publishing.

Exclusive

ERC research funding overwhelmed by applications, raising lottery concerns

The European Research Council, an elite research funder, is being swamped by applications, prompting questions about whether funding decisions are becoming a lottery. The surge matters because it could affect how scientists compete for scarce research money and how funding bodies manage demand.

Exclusive

Four charts show how the pandemic shifted public trust in science

Nature presents four charts tracing how public trust in science changed during the COVID-19 pandemic. The analysis highlights shifts and disparities in confidence that matter for vaccine uptake, health policy, and science communication.